Cardiol Therapeutics/CRDL

$1.80

-3.23%
-
1D1W1MYTD1YMAX

About Cardiol Therapeutics

Cardiol Therapeutics Inc. is a clinical-stage life sciences company. The Company is focused on the research and clinical development of anti-inflammatory and anti-fibrotic therapies for the treatment of heart disease. Its lead drug candidate, CardiolRx (cannabidiol) oral solution, is pharmaceutically manufactured and in clinical development for use in the treatment of heart disease. It is recognized that cannabidiol inhibits activation of the inflammasome pathway, an intracellular process known to play an important role in the development and progression of inflammation and fibrosis associated with myocarditis, pericarditis, and heart failure. It is also developing CRD-38, a novel subcutaneously administered drug intended for use in heart failure. It has received Investigational New Drug Application authorization from the United States Food and Drug Administration to conduct clinical studies to evaluate the efficacy and safety of CardiolRx in two diseases affecting the heart.

Ticker

CRDL

Sector

Healthcare

Trading on

NASDAQ

Industry

Biotechnology & Drugs

CEO

David Elsley

Employees

17

Headquarters

Oakville, Canada

CRDL Metrics

BasicAdvanced
$174.88M
Market cap
-
P/E ratio
-$0.44
EPS
0.71
Beta
-
Dividend rate
$174.88M
0.70818
$2.94
$0.68
152.43K
4.358
0.561
0.617
-56.98%
-69.93%
-69.77%
5.9
6.238
11.86%

What the Analysts think about CRDL

Analyst Ratings

Majority rating from 2 analysts.
Buy

Price Targets

Average projection from 2 analysts.
63.33% upside
High $3.27
Low $2.62
$1.80
Current price
$2.94
Average price target

CRDL Financial Performance

Income StatementBalance sheetCash Flow

Income Statement

Revenues and expenses
0% profit margin
QuarterlyAnnual
Q4 23
QoQ growth
Revenue
CA$0
-
Net income
CA$-7.6M
28.81%
Profit margin
0%
-

CRDL Earnings Performance

Earnings per share (EPS)

Company profitability
Missed by 0%
QuarterlyAnnual
Q1 23
Q2 23
Q3 23
Q4 23
Q1 24
Actual
-CA$0.11
-CA$0.12
-CA$0.09
-CA$0.12
-
Expected
-CA$0.15
-CA$0.13
-CA$0.12
-CA$0.12
-CA$0.13
Surprise
-26.67%
-4%
-25%
0%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. Fundamental data, financials and analyst ratings are sourced from Refinitiv.

Upcoming events

FAQs

What’s the current market cap for Cardiol Therapeutics stock?

Cardiol Therapeutics (CRDL) has a market cap of $174.88M as of April 15, 2024.

What is the P/E ratio for Cardiol Therapeutics stock?

The price to earnings (P/E) ratio for Cardiol Therapeutics (CRDL) stock is 0 as of April 15, 2024.

Does Cardiol Therapeutics stock pay dividends?

No, Cardiol Therapeutics (CRDL) stock does not pay dividends to its shareholders as of April 15, 2024.

When is the next Cardiol Therapeutics dividend payment date?

Cardiol Therapeutics (CRDL) stock does not pay dividends to its shareholders.

What is the beta indicator for Cardiol Therapeutics?

Cardiol Therapeutics (CRDL) has a beta rating of 0.71. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.

What is the Cardiol Therapeutics stock price target?

The target price for Cardiol Therapeutics (CRDL) stock is $2.94, which is 63.33% above the current price of $1.8. This is an average based on projections from 2 analysts, and represents their view of what the stock price could be in 12 or 18 months. This should not be seen as investment advice - Lightyear does not carry out investment research.

Buy or sell Cardiol Therapeutics stock

Buy or sell Cardiol Therapeutics stock

Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.
Start investing